Abstract: Example systems, methods and machine readable storage media to present information from different information systems in a local record are disclosed herein. An example method includes initiating communication with a first information system and a second information system, the first information system connected to a local system via a local network, the second information system connected to the local system via an external network. The example method also includes utilizing an identifier to identify a first query key associated with the first information system and a second query key associated with the second information system. The example method also includes generating a local record in the local system, importing first patient information from the first information system via the first query key to the local record, and importing second patient information from the second information system via the second query key to the local record.

Abstract: An ear-level device which can be operable in multiple modes supports a voice menu by which more complex functions executable by the ear-level device or by a companion module can be selected using input at the ear-level device. By pushing a button on an earpiece for example, a voice menu is activated announcing a set of functions such as voice dial, last number redial and so on. When the function that the user wants is announced, the user presses the same button which activates the execution of the function.

Abstract: Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a biguanide and a bile acid sequestrant. Drug products including a biguanide and bile acid sequestrants in combination are also disclosed.

Abstract: Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof. Drug products including a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof, in combination are also disclosed.

Abstract: A method controls a functional element of an ear-level device of a type including a functional element, a memory, a microphone and a speaker, each coupled to a processor. Communication between the ear-level device and a companion device, such as a mobile phone, is established. A functional element for control is selected through the user interface of the companion device. A control instruction for controlling the selected functional element is chosen using the user interface and is transmitted from the companion device to the ear-level device to provide instruction to the ear-level device to control the selected functional element in the chosen way.

Abstract: Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof. Drug products including a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof, in combination are also disclosed.

Abstract: Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co- administration of a biguanide and a bile acid sequestrant. Drug products including a biguanide and bile acid sequestrants in combination are also disclosed.

Abstract: A method controls a functional element of an ear-level device of a type including a functional element, a memory, a microphone and a speaker, each coupled to a processor. Communication between the ear-level device and a companion device, such as a mobile phone, is established. A functional element for control is selected through the user interface of the companion device. A control instruction for controlling the selected functional element is chosen using the user interface and is transmitted from the companion device to the ear-level device to provide instruction to the ear-level device to control the selected functional element in the chosen way.

Abstract: An ear-level device which can be operable in multiple modes supports a voice menu by which more complex functions executable by the ear-level device or by a companion module can be selected using input at the ear-level device. By pushing a button on an earpiece for example, a voice menu is activated announcing a set of functions such as voice dial, last number redial and so on. When the function that the user wants is announced, the user presses the same button which activates the execution of the function.

Abstract: Methods of treating diseases such as diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof. Drug products including a bile acid sequestrant and two or more additional compounds selected from the group consisting of a biguanide, a sulfonylurea and insulin, or pharmaceutically acceptable salts thereof, in combination are also disclosed.

Abstract: Methods of treating diseases diabetes are disclosed. Methods of modulating elevated fructosamine levels, elevated HbA1c levels, impaired glucose tolerance, and impaired fasting glucose are also disclosed. In some embodiments, methods include co-administration of a biguanide and a bile acid sequestrant. Drug products including a biguanide and bile acid sequestrants in combination are also disclosed.

Abstract: A touch screen for LCDs which uses a plurality of shockwave detectors disposed around the periphery of the viewing area to detect the location of a touch or tap which is the point of origin of an expanding shockwave.

Abstract: A system provides a user with free Internet network access, in which an access control system sends video advertising files to a user who gains access to the Internet through a network connection that includes a viewer program that operates independently of the user's browser and e-mail programs. The viewer receives ads from the access control system and manages an ad pool that collects multiple video advertising files. Video advertising files are downloaded when the user is not actively using the bandwidth of the Internet connection to download Internet content of the user's choosing. The viewer program periodically opens a viewer window, which opens on top of any other open windows, and in which a video ad from the ad pool is displayed. When one or more video ads are finished, the viewer window is hidden or made an inactive window for a quiet interval. At the conclusion of the quiet interval, the viewer window is activated and the next ad in the ad pool is displayed.

Abstract: A display includes a light source. The display also includes a filter positioned to receive light from the light source. The filter is a dye-based filter and attenuates light in the infrared range. The filter can be configured to have a very sharp spectral cutoff. The filter can be an NVIS filter. The display can be utilized in an avionic display system with night vision equipment. The filter can include a host polymer doped with a dye including cobalt or nickel.

Abstract: A container assembly for bulk materials and a kit for assembling same are disclosed. A forming member having a plurality of sidewalls defines an internal cavity for receiving bulk materials. The sidewalls are arranged relative to one another and are locked into position so as to define a geometric volume of predetermined shape, by means of a locking assembly. The locking assembly can be integrally attached to or can be separable from the sidewalls, and can form a bottom of the container assembly. A tubular sleeve of continuous material is sized to snugly engage and overlie substantially the entire outer surface area of the sidewalls. The sleeve provides the containment strength, while the forming member provides structural shape and stability to the container assembly. Additional layers of corrugated material or woven polypropylene material or their combination may be used as inserts engaging the inner peripheral sidewall areas of the forming member to provide additional strength to the container assembly.

Abstract: A new and efficient way of structuring databases enabling efficient query processing, reduced database storage requirements, and more flexible content targeting is described. A database is defined having bit mapped data. The data to be stored in the database is characterized as a number of binary questions. Each record comprises one or more groups of bit maps corresponding to the answers to the questions. For some types of data, there may be two or more possible values. In such cases, each possible value is itself a binary question. In some cases, there may be data which does not lend itself to characterization as binary questions. In such cases, the database includes numeric and string values. Queries of the database may be obtained through simple bit wise Boolean operations directly of the records in the database.

Abstract: A display includes a light source. The display also includes a filter positioned to receive light from the light source. The filter is a dye-based filter and attenuates light in the infrared range. The filter can be configured to have a very sharp spectral cutoff. The filter can be an NVIS filter. The display can be utilized in an avionic display system with night vision equipment. The filter can include a host polymer doped with a dye including cobalt or nickel.

Abstract: An optically addressed direct view photo luminescent display having a phosphor panel having multi-color pixelated surface with molecularly aligned materials therein and a printed bar code pixel identifier on an internal side for providing feedback of scanning beam to pixel registration.

Abstract: An optically addressed photo luminescent display having a printed bar code pixel identifier on an internal side for providing feedback of scanning beam to pixel registration.

Abstract: A liquid crystal display includes at least one polarizer located interior or internally of substrates of the display. In certain embodiments, the polarizer may be spin-coated onto the interior of one of the substrates, preferably the passive substrate of the display. Such a polarizer may also be located interior of color filters on the copassive substrate. Thus, light being transmitted through the display proceeds through the front polarizer prior to being de-polarized by the color filters. The result is improved contrast ratios in the display due to the minimization of the de-polarizing of color filters. In certain embodiments, the internal polarizer(s) may be photo-patternable by way of ultraviolet photo-imaging.